PCLO and hepatocellular carcinoma: We found that differentially expressed CDGs had high mutation rates in HCC, with TP53 showing the highest mutation rate (30%) followed by CTNNB1 (25%), TTN (24%), MUC16 (14%), ALB (13%), and PCLO (10%).